Researchers at Westmead Institute for Medical Research identified a unique subset of human cells involved in the immune response against hepatitis B. The discovery could lead to new treatments and improved vaccines for HBV infection.
Researchers redefine Non-Alcoholic Fatty Liver Disease (NAFLD) as Metabolic Associated Fatty Liver Disease (MAFLD), a condition characterized by liver fat build-up affecting over 1 billion people. The new definition aims to improve treatment pathways, trial design, and drug development for this disease.
Researchers from The Westmead Institute for Medical Research have discovered how fatty liver disease develops in lean people. Lean patients tend to have worse outcomes due to an 'obesity-resistant' profile, despite having higher levels of bile acids and FGF19, which increase energy expenditure.
A new study demonstrates dual DNA barcoding improves diagnosis of invasive fungal diseases, enabling faster treatment and reducing morbidity and mortality. The technique uses two specific regions of DNA to identify fungal pathogens, increasing accuracy and speed of diagnosis.
A recent study published in the Journal of Cachexia, Sarcopenia and Muscle found that vitamin D signaling is crucial for maintaining normal muscle size and strength. Researchers discovered that mice lacking vitamin D receptors in their muscle cells had smaller muscles and reduced physical performance.
Researchers have identified CD11c+ dendritic cells as the first immune cells to interact with HIV, making them key drivers of infection. These newly discovered cells can capture viruses and deliver them to CD4 T cells, which are primary targets for HIV replication.
A new method using flow cytometry has been developed to measure the immune response in islet transplant recipients. This standardized approach helps predict patient outcomes and could enable early intervention to prevent rejection.
Researchers identified a critical role for hypoxia-inducible factor 1-alpha (HIF-1A) in increasing the risk of type 1 diabetes after viral infections. The study suggests that exposure to coxsackievirus and other environmental triggers can lead to β-cell death and increased incidence of type 1 diabetes.
A new study from The Westmead Institute for Medical Research has found that Cryptococcus neoformans remodels lipids to release phosphate when phosphate is scarce. This strategy allows the fungus to conserve phosphate and survive in humans, a key finding with potential implications for treatment.
A new study from The Westmead Institute for Medical Research identified a genetic variant associated with liver fibrosis in chronic hepatitis C patients. This finding is crucial for preventing health complications and reducing the number of patients requiring liver transplants.
New research suggests that moderate water intake can reduce kidney cyst growth and fibrosis in people with polycystic kidney disease (PKD). Increased water consumption was also found to have secondary benefits, including reducing high blood pressure and cardiovascular risks associated with PKD.
Researchers found three genetic variations linked to increased liver fat, which could lead to new treatment options for non-alcoholic fatty liver disease (NAFLD). The study, led by Westmead Institute for Medical Research, identified the mechanisms behind hepatic steatosis, a major risk factor for NAFLD.
A new study published in the Journal of the Academy of Nutrition and Dietetics found that consuming vegetable nitrates, primarily from green leafy vegetables and beetroot, can reduce the risk of early-stage age-related macular degeneration by 35%. Eating 100-142mg of vegetable nitrates daily was associated with this reduced risk.
A new test predicts advanced fibrosis in NAFLD patients, accurately identifying 92% of those at risk. The tool uses the PRO-C3 biological marker and combines it with clinical information for highly accurate results.
Researchers found that brain activity in the amygdala responds differently to facial expressions in individuals with bipolar disorder versus those with depression. The study demonstrated 80% accuracy in distinguishing between the two conditions. This finding holds promise for improving diagnosis and treatment of these disorders.
Research using brain scans found that neurons in the amygdala respond differently in people with bipolar disorder versus those with depression. The study showed an 80% accuracy rate in distinguishing between the two conditions. This discovery could lead to more accurate diagnoses and better treatment outcomes for patients.
Researchers have discovered that women with low-grade serous ovarian cancer and a BRAF gene mutation experience excellent responses to BRAF inhibitor treatments. This finding is encouraging for patients who may not respond to conventional chemotherapy.
A new study found that genetic variation in Caucasians with chronic hepatitis B infection increases the risk of severe liver damage and inflammation. Researchers identified a link between the STAT4 gene and liver fibrosis, suggesting that genetic factors may play a role in disease progression.
A 15-year study found that people who eat at least one serving of oranges daily have a 60% reduced risk of developing late macular degeneration. Flavonoids in oranges appear to help prevent against the eye disease.
Researchers have identified a potentially new approach to treating lethal fungal infections by starving the fungi of essential nutrients. The team found that blocking the phosphate starvation response prevents the spread of infection in mice, offering a novel treatment avenue for patients with weakened immune systems.
Research found a link between poorer health-related quality of life in adolescence and increased risk of cardiovascular disease. Adolescents with lower scores in social and mental well-being domains had structural changes in their retinal blood vessels, which could be indicative of future cardiovascular disease risk.
New research reveals that CD4+Foxp3+ regulatory T-cells (Tregs) are closely linked to ALS progression, with patients having higher numbers of Tregs experiencing slower disease progression. This discovery provides a promising approach for developing new therapies to treat ALS.
New research suggests that vitamin D may protect heart tissue and reduce the risk of heart failure after a heart attack. The study found that vitamin D prevents excessive scarring and thickening of heart tissue following a heart attack, which can lead to heart failure.
The new Shingrix vaccine has been shown to be more than 90% effective in protecting against the herpes zoster virus, which causes chickenpox and shingles. The vaccine stimulates production of immune memory cells, generating a strong and sustained protection against the virus.
Research identified gene variant ABCC2's role in eliminating chemotherapy, affecting treatment response. Variants associated with high drug elimination rates may lead to reduced treatment effectiveness.
Researchers at Westmead Institute for Medical Research are conducting a new clinical trial using water to treat polycystic kidney disease. The PREVENT-ADPKD trial aims to investigate whether drinking the right amount of water can prevent adult polycystic kidney disease (ADPKD) from progressing to kidney failure.
Researchers identified specific immune memory T-cells as the site where HIV hides to evade detection, revealing a key target for future therapies. This discovery provides new insights into the chronic illness and offers potential avenues for developing a cure.
Web-based treatments have been found to significantly increase employment rates among individuals with severe mental illness. The studies show that participants worked for three times the number of hours and earned almost $2000 more than the control group.
A team of researchers from Sydney's Westmead Institute for Medical Research has discovered a new drug target, Arg1, to combat life-threatening fungal infections. The protein enables Cryptococcus neoformans fungus to establish fatal infections in patients with weakened immune systems.
Researchers identified how HIV induces antiviral interferon-stimulated genes in infected cells to survive and spread, hindering the body's early immune response. The study aims to boost expression of these genes to stop virus replication.
Researchers at Westmead Institute for Medical Research have discovered a new approach to treating type 1 diabetes, using pancreatic islet transplants delivered into the quadriceps muscle. This method presents fewer risks than current clinical practice of transplanting islets into the liver via the portal vein.
A new review paper outlines the gold standard for identifying at-risk patients, preventing, diagnosing, and treating invasive fungal infections. Early and correct treatment leads to better outcomes for patients, reducing mortality rates from up to 85% in critically ill patients.
Australian researchers have developed a world-first test to identify patients at risk of developing serious secondary infections. The High-risk Influenza Screen Test measures an early warning signal released by the patient's body, predicting potential complications with high accuracy.
Researchers discover zinc's anti-inflammatory effects in treating liver disease, inhibiting IFN-λ3 protein that causes tissue damage. Serum zinc levels are genetically linked to chronic hepatitis C progression.
Researchers have identified a protein causing liver fibrosis, paving the way for new treatments. The discovery, led by Professor Jacob George and Doctor Mohammed Eslam, reveals that variations in the interferon lambda 3 (INLF3) protein are responsible for tissue damage in the liver.